<DOC>
	<DOC>NCT01511250</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and tolerability of a dengue vaccine administered subcutaneously in healthy adults and children. In addition the antibody response to the four dengue virus serotypes will be evaluated.</brief_summary>
	<brief_title>Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years</brief_title>
	<detailed_description />
	<mesh_term>Dengue</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>In good health Normal laboratory values at screening Abnormal ECG History of significant dermatologic (skin) disease within last 6 months Diabetes mellitus History of any immunodeficiency History of recurring headaches or migraines Hypersensitivity to vaccines Use of amphetamines, opiates, cannabinoids History of alcohol abuse Pregnant or lactating female</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>normal healthy adults and children</keyword>
	<keyword>Safety and tolerability</keyword>
	<keyword>active vaccine</keyword>
	<keyword>placebo</keyword>
	<keyword>Dengue virus vaccine</keyword>
	<keyword>Immune response</keyword>
</DOC>